Cell & Gene: The Podcast Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.
Feb 1, 2024
Jennifer Klarer from The Dedham Group delves into pricing and value for CGTs, addressing misconceptions and solutions. Topics include time to treatment challenges, securing investment, and payer dynamics. Learn about the importance of early commercial planning and navigating evolving payment models for financial stability.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Key Considerations for Launching Cell & Gene Therapy
03:07 • 5min
Navigating Payer Dynamics and Coverage Policies for Expensive Therapies
07:52 • 8min
Early Integration of Commercial Planning for Effective Product Launch
15:23 • 3min
Navigating Pricing and Value in Cell and Gene Therapy
18:27 • 19min